By Professor Ric Day

Journal articles

Sandhu GS; Day RO, 1992, 'Factors affecting prescribing in general practice - A role play', Medical Journal of Australia, 157, pp. 621 - 622, http://dx.doi.org/10.5694/j.1326-5377.1992.tb137406.x

Zhao B; Geisslinger G; Hall I; Day RO; Williams KM, 1992, 'The effect of the enantiomers of ibuprofen and flurbiprofen on the β‐oxidation of palmitate in the rat', Chirality, 4, pp. 137 - 141, http://dx.doi.org/10.1002/chir.530040302

Lau AT; Graham GG; Day RO; Perry MA, 1992, 'Effect of aspirin on ulcer site blood flow in cat stomachs.', Am J Physiol, 263, pp. G155 - G160, http://dx.doi.org/10.1152/ajpgi.1992.263.2.G155

FUGER KE; WIENBECK M; MANN J, 1991, 'NONSTEROIDAL ANTIINFLAMMATORY DRUGS - DIFFERENCES AND SIMILARITIES', NEW ENGLAND JOURNAL OF MEDICINE, 325, pp. 1653 - 1653, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991GR77000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Füger KE; Wienbeck M; Mann J; Kornowski R; Aderka D; Schwartz D; Levo Y; Djahanguiri B; Brooks P; Day RO, 1991, 'Nonsteroidal antiinflammatory drugs — differences and similarities', New England Journal of Medicine, 325, pp. 1653 - 1654, http://dx.doi.org/10.1056/NEJM199112053252314

Day R; Seideman P, 1991, 'NSAIDs, musculoskeletal disorders and gastrointestinal adverse effects.', Australian family physician, 20, pp. 1735 - 1737

Williams KM; Knihinicki RD; Day RO, 1991, 'Pharmacokinetics of the enantiomers of ibuprofen in the rabbit', Agents and Actions, 34, pp. 381 - 386, http://dx.doi.org/10.1007/BF01988732

Knihinicki RD; Day RO; Williams KM, 1991, 'Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-II Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters', Biochemical Pharmacology, 42, pp. 1905 - 1911, http://dx.doi.org/10.1016/0006-2952(91)90588-V

Brooks PM; Day RO, 1991, 'Nonsteroidal Antiinflammatory Drugs — Differences and Similarities', New England Journal of Medicine, 324, pp. 1716 - 1725, http://dx.doi.org/10.1056/NEJM199106133242407

Joyce DA; Day RO; Murphy BR, 1991, 'The pharmacokinetics of albumin conjugates of D-penicillamine in humans', Drug Metabolism and Disposition, 19, pp. 309 - 311

Birkett D; Miners J; Day R, 1991, '1‐Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect.', British Journal of Clinical Pharmacology, 32, pp. 238 - 241, http://dx.doi.org/10.1111/j.1365-2125.1991.tb03888.x

Kino R; Day RO; Pearce GA; Fulde GWO, 1991, 'Aminophylline in the emergency department: Maximizing safety and efficacy', Chest, 100, pp. 1572 - 1577, http://dx.doi.org/10.1378/chest.100.6.1572

Kino R; Day RO; Pearce GA; Fulde GWO, 1991, 'Bedside measurement of plasma theophylline concentration within the emergency department', Australian Journal of Hospital Pharmacy, 21, pp. 292 - 294

Winn JS; Guille J; Gebicki JM; Day RO, 1991, 'Hydrogen peroxide modulation of the respiratory burst of human neutrophils', Biochemical Pharmacology, 41, pp. 31 - 36, http://dx.doi.org/10.1016/0006-2952(91)90007-R

Handel ML; DeFazio A; Watts CKW; Day RO; Sutherland RL, 1991, 'Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions', Molecular Pharmacology, 40, pp. 613 - 618

Day RO; Williams KM; Graham S; Handel M, 1991, 'The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma', Arthritis & Rheumatism, 34, pp. 751 - 760, http://dx.doi.org/10.1002/art.1780340617

Johnson AG; Day RO, 1991, 'The Problems and Pitfalls of NSAID Therapy in the Elderly (Part I)', Drugs & Aging, 1, pp. 130 - 143, http://dx.doi.org/10.2165/00002512-199101020-00005

Johnson AG; Day RO, 1991, 'The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)', Drugs & Aging, 1, pp. 212 - 227, http://dx.doi.org/10.2165/00002512-199101030-00005

Nuernberg B; Knihinicki R; Williams K; Freeman GE; Dalton C; Brooks PM; Day RO, 1990, 'Anti-inflammatory effects and disposition of S- and R-flurbiprofen in the rat', European Journal of Pharmacology, 183, pp. 1591 - 1592, http://dx.doi.org/10.1016/0014-2999(90)94757-O

Johnson AG; Day RO; Seldon WA, 1990, 'A functional psychosis precipitated by quinidine', Medical Journal of Australia, 153, pp. 47 - 49, http://dx.doi.org/10.5694/j.1326-5377.1990.tb125463.x

Tett S; Cutler D; Day R, 1990, 'Antimalarials in rheumatic diseases', Bailliere's Clinical Rheumatology, 4, pp. 467 - 489, http://dx.doi.org/10.1016/S0950-3579(05)80004-4

Pearce GA; Day RO, 1990, 'Compliance with criteria necessary for effective drug concentration monitoring', Therapeutic Drug Monitoring, 12, pp. 250 - 257, http://dx.doi.org/10.1097/00007691-199005000-00007

Joyce D; Day R, 1990, 'D‐penicillamine and D‐penicillamine‐protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.', British Journal of Clinical Pharmacology, 30, pp. 511 - 517, http://dx.doi.org/10.1111/j.1365-2125.1990.tb03808.x

Tett SE; Cutler DJ; Day RO, 1990, 'Hydroxychloroquine concentrations and clinical effects in rheumatoid arthritis patients', European Journal of Pharmacology, 183, pp. 1035, http://dx.doi.org/10.1016/0014-2999(90)92892-M

Knihinicki RD; Day RO; Graham GG; Williams KM, 1990, 'Stereoselective disposition of ibuprofen and flurbiprofen in rats', Chirality, 2, pp. 134 - 140, http://dx.doi.org/10.1002/chir.530020303

Knihinicki RD; Williams KM; Day RO, 1989, 'Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-1. In vitro studies of ibuprofen and flurbiprofen', Biochemical Pharmacology, 38, pp. 4389 - 4395, http://dx.doi.org/10.1016/0006-2952(89)90647-3

Sambrook PN; Champion GD; Browne CD; Cairns D; Cohen ML; Day RO; Graham S; Handel M; Jaworski R; Kempler S; Wach er T, 1989, 'Corticosteroid injection for osteoarthritis of the knee: Peripatellar compared to intra-articular route', Clinical and Experimental Rheumatology, 7, pp. 609 - 613

Day R, 1989, 'Trends in the treatment of rheumatoid arthritis: Australia', Rheumatology SEAPAL 1988: proceedings of the 6th SEAPAL Congress of rheumatology. ICS809, pp. 159 - 161

Tett S; Cutler D; Day R; Brown K, 1989, 'Bioavailability of hydroxychloroquine tablets in healthy volunteers.', British Journal of Clinical Pharmacology, 27, pp. 771 - 779, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03439.x

Graham SR; Day RO; Hardy M, 1989, 'Captopril overdose', Medical Journal of Australia, 151, pp. 111, http://dx.doi.org/10.5694/j.1326-5377.1989.tb101174.x

Day R; Graham G; Bieri D; Brown M; Cairns D; Harris G; Hounsell J; Platt‐ Hepworth S; Reeve R; Sambrook P; et al , 1989, 'Concentration‐response relationships for salicylate‐induced ototoxicity in normal volunteers.', British Journal of Clinical Pharmacology, 28, pp. 695 - 702, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03562.x

HO KY; WEISSBERGER AJ; STUART MC; DAY RO; LAZARUS L, 1989, 'THE PHARMACOKINETICS, SAFETY AND ENDOCRINE EFFECTS OF AUTHENTIC BIOSYNTHETIC HUMAN GROWTH HORMONE IN NORMAL SUBJECTS', Clinical Endocrinology, 30, pp. 335 - 345, http://dx.doi.org/10.1111/j.1365-2265.1989.tb00431.x

Bowden GJ; Cadogan JM; Day RK; Dunlop JB, 1988, '¹⁶⁹Tm Mössbauer experiments in the paramagnetic phase of Tm2 Al', Hyperfine Interactions, 39, pp. 359 - 367, http://dx.doi.org/10.1007/BF02397645

Stewart GA; Day RK; Dunlop JB; Price DC, 1988, 'A two-site analysis of¹⁶⁹Tm Mössbauer measurements on thulium sesquioxide', Hyperfine Interactions, 40, pp. 339 - 342, http://dx.doi.org/10.1007/BF02049112

Patapanian H; Graham S; Sambrook PN; Browne CD; Champion GD; Cohen ML; Day RO, 1988, 'The oncogenicity of chlorambucil in rheumatoid arthritis', Rheumatology, 27, pp. 44 - 47, http://dx.doi.org/10.1093/rheumatology/27.1.44

Tett S; Cutler D; Day R; Brown K, 1988, 'A dose‐ranging study of the pharmacokinetics of hydroxy‐chloroquine following intravenous administration to healthy volunteers.', British Journal of Clinical Pharmacology, 26, pp. 303 - 313, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05281.x

Day R; Miners J; Birkett D; Whitehead A; Naidoo D; Hayes J; Savdie E, 1988, 'Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.', British Journal of Clinical Pharmacology, 26, pp. 423 - 428, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03401.x

Day RO; Breit SN; Cairns D; Champion GD, 1988, 'Aspects of the clinical trials of slow-acting anti-rheumatic drugs.', Agents and actions. Supplements, 24, pp. 121 - 133, http://dx.doi.org/10.1007/978-3-0348-9160-8_11

Day RO; Furst DE; Dromgoole SH; Paulus HE, 1988, 'Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers', Biopharmaceutics & Drug Disposition, 9, pp. 273 - 283, http://dx.doi.org/10.1002/bod.2510090306

Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; De Jager J; Sambrook PN, 1988, 'Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis', Journal of Rheumatology, 15, pp. 28 - 34

Day R; Harris G; Brown M; Graham G; Champion G, 1988, 'Interaction of salicylate and corticosteroids in man.', British Journal of Clinical Pharmacology, 26, pp. 334 - 337, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05286.x

Day RO, 1988, 'Mode of action of non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 148, pp. 195 - 199, http://dx.doi.org/10.5694/j.1326-5377.1988.tb112818.x

Graham SR; Day RO; Lee R; Fulde GWO, 1988, 'Overdose with chloral hydrate: A pharmacological and therapeutic review', Medical Journal of Australia, 149, pp. 686 - 688, http://dx.doi.org/10.5694/j.1326-5377.1988.tb120823.x

Day RO; Graham GG; Williams KM, 1988, 'Pharmacokinetics of non-steroidal anti-inflammatory drugs', Bailliere's Clinical Rheumatology, 2, pp. 363 - 393, http://dx.doi.org/10.1016/S0950-3579(88)80019-0

Day R; Miners J; Birkett D; Graham G; Whitehead A, 1988, 'Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.', British Journal of Clinical Pharmacology, 26, pp. 429 - 434, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03402.x

Day RO; Williams KM; Graham GG; Lee EJ; Knihinicki RD; Champion GD, 1988, 'Stereoselective disposition of ibuprofen enantiomers in synovial fluid', Clinical Pharmacology and Therapeutics, 43, pp. 480 - 487, http://dx.doi.org/10.1038/clpt.1988.62

Williams KM; Day RO, 1988, 'The contribution of enantiomers to variability in response to anti-inflammatory drugs.', Agents and actions. Supplements, 24, pp. 76 - 84, http://dx.doi.org/10.1007/978-3-0348-9160-8_7

Day R; Paull P; Lam S; Swanson B; Williams K; Wade D, 1988, 'The effect of concurrent aspirin upon plasma concentrations of tenoxicam.', British Journal of Clinical Pharmacology, 26, pp. 455 - 462, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03405.x

Keogh A; Day R; Critchley L; Duggin G; Baron D, 1988, 'The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients', Transplantation Proceedings, 20, pp. 27 - 30

Day RO; Graham GG; Willia KM; Brooks PM, 1988, 'Variability in Response to NSAIDs: Fact or Fiction?', Drugs, 36, pp. 643 - 651, http://dx.doi.org/10.2165/00003495-198836060-00001

Back to profile page